Tobacco companies and academics questioned on e-cigarettes
22 February 2018
The Science and Technology Committee continues its inquiry on e-cigarettes. This Session hears from four tobacco companies about their own research on the health effect of e-cigarette devices and the second panel examines the toxicity of e-cigarettes, and how puffing behaviours, settings of the device or other factors may affect the toxicity.
Tuesday 27 February 2018, Wilson Room, Portcullis House
- Dr Ian Jones, Vice President, Reduced-Risk Products, Japan Tobacco International
- Dr Chris Proctor, Chief Scientific Officer, British American Tobacco
- Dr Moira Gilchrist, Vice President, Scientific and Public Communications, Philip Morris Limited
- Dr Grant O'Connell, Regulatory and Scientific Affairs, Fontem Ventures
- Professor David Harrison, Chair of the UK Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC)
- Dr Lynne Dawkins, Associate Professor, London Southbank University Behavioural Science Centre
The Committee held its first session on e-cigarettes on the 9 January 2018, hearing from academics about the current research findings around the harmfulness around e-cigarettes, its potential as a smoking cessation tool and its possible “gate way” effect on smoking.